WARREN, N.J., March 10, 2017 /PRNewswire/ --áRoka Bioscience, Inc. (NASDAQ:ROKA), a molecular diagnostics company focusedon providing advanced testing solutions for the detection of foodborne pathogens, átoday announced that Mary Duseau, CEO will present at the 29th Annual Roth Conference on March 14
About Roka Bioscience
Roka Bioscience is a molecular diagnostics company focused on developing and commercializing advanced testing solutions for the food safety testing market. Our Atlas Detection Assays incorporate our advanced molecular technologies and are performed on our "sample-in, result-out" Atlas System that automates all aspects of molecular diagnostic testing on a single, integrated platform. The Atlas System and Detection Assays are designed to provide our customers with accurate and rapid test results with reduced labor costs and improved laboratory efficiencies.á For more information, visit http://rokabio.com.
Investor Contact:Roka Bioscience, [email protected]855-ROKABIO (855-765-2246)
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/roka-bioscience-to-present-at-the-29th-annual-roth-conference-300421537.html
SOURCE Roka Bioscience, Inc.
Subscribe to our Free Newsletters!
Hand hygiene is a simple and affordable technique to prevent infections.
Erythropoietin is a hormone secreted by kidneys in response to low oxygen levels in tissues ...
Local anesthesia is a type of anesthesia generally used to block pain sensation only in a specific ...View All